Hematology
From the Journals
Reversal agents curb DOAC-related bleeding but deaths still high
The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.
From the Journals
First year of life sees initial bleeding episodes in children with von Willebrand disease
From the Journals
Patients with CLL have significantly reduced response to COVID-19 vaccine
Less than half of CLL patients had an antibody-mediated response to the Pfizer vaccine in a study.
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
From the Journals
AHA guidance on blood clots linked to COVID-19 vaccine
News
How some COVID-19 vaccines could cause rare blood clots
Six cases of a rare but serious event in patients who got the J&J vaccine are being reviewed.
From the Journals
COVID-19 vaccine failure in patients with blood cancers
Conference Coverage
Bleeding disorder diagnoses delayed by years in girls and women
Conference Coverage
Safety profiles of hemophilia agents vary widely
Conference Coverage
Factor VIII concentrate is here to stay in hemophilia A
Feature
Full-dose anticoagulation reduces need for life support in COVID-19